Hims & Hers Health, Inc. (HIMS) closed at $29.76 in the latest trading session, marking a -4.03% move from the prior day. This change lagged the S&P 500's daily loss of 0.64%. At the same time, the ...

Telehealth investors weigh Amazon’s new anti-obesity drug push against this platform’s recent rapid growth, today, April 21, ...

Hims & Hers Health (NYSE:HIMS) shares are up 9% in early trading Monday, climbing from $28.82 to $31 and change as investors ...

Hims & Hers Health, Inc. HIMS has increasingly positioned itself at the intersection of healthcare and data, building a ...

Hims & Hers saw its share prices jump by 48.3 percent week-on-week as investors positioned portfolios ahead of the results of ...

Hims & Hers (HIMS) stock is down ~40% YTD but remains a "Buy." Learn why compressed valuation and Eucalyptus-led Europe/Japan ...

Shares of Hims & Hers Health (NYSE:HIMS) rose more than 8% to about $26 after the US Food and Drug Administration (FDA) moved ...

The world of health care has officially moved into the “add to cart” era, and Hers — the feminine counterpart to the Hims ...

Artificial intelligence could be a big differentiator for Hims & Hers.

Hims & Hers Health (NYSE:HIMS) just got a fresh look from Bank of America, which raised its price target on the stock to $25 from $21 while maintaining a Neutral rating. The catalyst: the FDA took a ...